← Leaderboards
Michael Louis Martini
Icahn School Of Medicine At Mount Sinai
$88,776
Attributed
$88,776
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $44.9K · FY2019–20$50K$37.5K$25K$12.5K$0
'19
'20
Funding mix
By agency
NIH$88,776 · 1
By mechanism
F30$88,776 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Marat V Avshalumov$99,144
- Marc R. Birtwistle$12,507,114
- Winnie Chen$96,752
- Scott J Russo$23,138,406
- Ann Jones Hessell$7,342,926
Others in their field
Other Emerging Leaders on “Degenerative Disorder”
- Birgit Schilling · Medical College Of Wisconsin$7,009,581
- Chang Hun Lee · Columbia University Health Sciences$5,341,536
- Frederic Geissmann · Sloan-Kettering Inst Can Research$4,469,958
- Maddalena Adorno · Dorian Therapeutics, Inc.$4,178,124
- Hang Lin · University Of Pittsburgh At Pittsburgh$3,889,833
- Seth Lawler Shipman · J. David Gladstone Institutes$3,628,777
Research focus
Degenerative DisorderAging PopulationCorpus Striatum StructureAnalogAnimalsAntiparkinson AgentsAdverse EffectsAdvanced DiseaseArtificial MembranesBaseBehaviorBeta-ArrestinBindingBinding SitesArr2AgonistArrestinsCarbidopaCatecholsCell Membrane PermeabilityCentral Nervous System DiseasesComplexComputer AnalysisDesensitization
Grant awards (2)
Beta-Arrestin-Biased Agonism at the D1 Receptor as a Novel Approach to Levodopa-Induced Dyskinesias in Advanced Parkinson's Disease$43,920
F30 · FY2020 · AG · contact PI
Beta-Arrestin-Biased Agonism at the D1 Receptor as a Novel Approach to Levodopa-Induced Dyskinesias in Advanced Parkinson's Disease$44,856
F30 · FY2019 · AG · contact PI